NCT02762513 2021-05-05
Expansion Trial for Axitinib In Head And Neck Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
Clinical Trials
5 trialsNCT02857712 2019-08-30
SGC-AX14
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Completed
NCT01469546 2016-08-29
Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00389441 2013-11-25
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
Pfizer
Phase 2 Completed
NCT00094055 2012-06-26
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
Pfizer
Phase 2 Completed